Nuveen Quality Municipal Income Fund
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NAD research report →
Range $11 – $11
Price Chart
About the company
The Nuveen Quality Municipal Income Fund (NAD) is a U. S. -domiciled, closed-end mutual fund that began operations on January 15, 1999, having previously been known as the Nuveen Dividend Advantage Municipal Fund.
- CEO
- Thomas C. Spalding Jr.
- IPO
- 1999
- HQ
- Chicago, IL, US
Get TickerSpark's AI analysis on NAD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.72B
- P/E
- 14.76
- PEG
- 0.07
- P/S
- 10.56
- P/B
- 0.98
- EV/EBITDA
- 18.50
- Div Yield
- 7.26%
- Gross Margin
- 83.73%
- Op Margin
- 62.82%
- Net Margin
- 71.39%
- ROE
- 6.51%
- ROIC
- 3.38%
Latest fiscal year · YoY change
- Revenue
- $205.57M+0.3%
- Gross Profit
- $177.48M-62.6%
- Op Income
- $143.34M
- Net Income
- $65.36M-86.0%
- EPS
- $0.28-86.0%
- OCF Growth
- +34.6%
- FCF Growth
- +34.6%
- 52W High
- $12.31
- 52W Low
- $11.11
- 50D MA
- $11.86
- 200D MA
- $11.92
- Beta
- 0.64
- RSI (14)
- 43
- Avg Volume
- 584.59K
No earnings-call transcripts are available for NAD yet.
- Free Float
- 100.1%
- Shares Outstanding
- 233.46M
- Float Shares
- 233.70M
of shares held by institutions
283 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Morgan Stanley | 6.66M | ▲ 25.22K |
| Guggenheim Capital LLC | 3.62M | ▲ 551.58K |
| Ubs Group AG | 3.12M | ▼ 67.96K |
| Wells Fargo & Company/Mn | 2.79M | ▲ 290.51K |
| Bank Of America Corp | 2.32M | ▼ 201.50K |
| Raymond James Financial Inc | 2.07M | ▼ 562.38K |
| Ameriprise Financial Inc | 1.38M | ▲ 148.81K |
| Hennion & Walsh Asset Management, Inc. | 1.37M | ▲ 445.35K |
| Mcgowan Group Asset Management, Inc. | 1.36M | ▼ 17.82K |
| Van Eck Associates Corp | 1.29M | ▲ 178.33K |
| Lpl Financial LLC | 1.27M | ▲ 42.87K |
| Royal Bank Of Canada | 990.97K | ▲ 28.42K |
Held by 3 ETFs
Biggest fund positions in NAD by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 10, 26 | WELLS FARGO & COMPANY/MN | other | 750 |
| Mar 11, 26 | WELLS FARGO & COMPANY/MN | other | 500 |
| Mar 5, 26 | Siffermann William A | buy | 100 |
| Oct 16, 25 | Castro Joseph | other | 0 |
| Sep 10, 25 | Page Robert Tanner | other | 0 |
| Jan 2, 26 | BANK OF AMERICA CORP /DE/ | buy | 6,374 |
| Jan 2, 26 | BANK OF AMERICA CORP /DE/ | sell | 6,374 |
| Apr 16, 25 | BANK OF AMERICA CORP /DE/ | buy | 2,103 |
| Apr 16, 25 | BANK OF AMERICA CORP /DE/ | sell | 2,103 |
| Mar 21, 25 | Siffermann William A | buy | 300 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NAD coverage
Recent articles, reports, and earnings notes.
No research on NAD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NAD report →Tru2u.health Expands Digital Health Platform with the Addition of NAD+ - The Cellular Energy Molecule Transforming Modern Wellness
newsfilecorp.com · Apr 29
Why Low Tax Muni Bonds Belong In Your Retirement Portfolio In 2026
seekingalpha.com · Apr 29
Nuveen Quality Municipal Income Fund (NYSE:NAD) Share Price Crosses Below Two Hundred Day Moving Average – Here’s What Happened
defenseworld.net · Apr 21
A Pair Trade Opportunity By Nuveen Quality Municipal Income Funds
seekingalpha.com · Apr 6
Nuveen Quality Municipal Income Fund (NYSE:NAD) Shares Pass Below Two Hundred Day Moving Average – Time to Sell?
defenseworld.net · Mar 28
Bramshill Sells Nuveen Quality Municipal Income Fund
fool.com · Mar 10
Niagen Bioscience is the Premiere Sponsor of the Inaugural “NAD for Health: Opportunities & Challenges” Conference Hosted by the University of Copenhagen
businesswire.com · Feb 9
Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S.*
businesswire.com · Jan 15
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.